Currents in Pharmaceutical Research
https://journals.umt.edu.pk/index.php/CPR
<p>Currents in Pharmaceutical Research (CPR) is an International open access peer-reviewed journal that aims to publish high-quality research in the field of pharmaceutical sciences. The journal welcomes contributions from researchers worldwide and encourages interdisciplinary approaches that integrate pharmaceutical science with other related fields. The journal aims to be a valuable resource for the pharmaceutical industry, regulatory bodies, and healthcare professionals seeking to enhance their understanding of drug development, evaluation, and use.</p>en-US<p>Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a <a href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution (CC-BY) 4.0 License</a> that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal</p>[email protected] (Prof. Dr. Ejaz Ullah Cheema)[email protected] (Ramna Zia)Fri, 15 May 2026 00:00:00 +0500OJS 3.1.2.1http://blogs.law.harvard.edu/tech/rss60Antimicrobial Peptides as Novel Therapeutics: An In-depth Exploration into Mechanisms, Resistance Challenges, and Clinical Prospects
https://journals.umt.edu.pk/index.php/CPR/article/view/8038
<p>Antimicrobial peptides (AMPs) play a crucial part in innate immunity. They are naturally occurring, short-chain peptides. Furthermore, they show a broad-spectrum of activity against a variety of bacteria and viruses, along with immunomodulatory effects. This dual therapeutic potential has raised researchers’ interest as an alternative to antibiotics. The majority of antimicrobials available in the market encounter resistance considerably. Whereas resistance of AMPs is subordinate due to their unique mechanism of action. In spite of such benefits, clinical translation of AMPs is still a challenge owing to their high manufacturing cost, toxicity, proteolytic instability, and microbial resistance. Current advancements in chemical modifications, peptide engineering, and nano delivery have emerged to address such challenges. The current study aimed to provide a comprehensive insight into resistance pathways, therapeutic applications, cellular mechanisms, critical analysis of in-progress clinical trials, structural features, and future perspectives. AMPs depicted significant interactions that modulate cytokine production, chemotaxis, and immune responses. This validates the role of AMPs as immune sentinels, regulating both adaptive and innate immunity, unlike usual antimicrobials. The key objective of this study was to explicate the organ level defensive role of AMPs in a comprehensive manner. Moreover, the study also explored multiple bacterial resistance tactics. Recent approaches, such as nano-carrier drug delivery systems, peptide engineering, and backbone modifications, enhanced evasion, tissue targeting and bioavailability of AMPs have also been traversed. By accentuating both opportunities and challenges, this study focused on the possible translational potential of AMPs in tackling the antimicrobial resistance (AMR) dilemma worldwide.</p>Faiza, Muhammad Asad Saeed, Muhammad Zaman
Copyright (c) 2026 Faiza, Muhammad Asad Saeed, Muhammad Zaman
https://creativecommons.org/licenses/by/4.0
https://journals.umt.edu.pk/index.php/CPR/article/view/8038Fri, 15 May 2026 00:00:00 +0500